Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel
Paul E. Sax, Melanie Thompson, Michael S. Saag, IAS-USA Treatment Guidelines Panel
Abstract
Rajesh T. Gandhi, MD; Roger Bedimo, MD; Jennifer F. Hoy, MBBS; Raphael J. Landovitz, MD; Davey M. Smith, MD; Ellen F. Eaton, MD; Clara Lehmann, MD; Sandra A. Springer, MD; Paul E. Sax, MD; Melanie A. Thompson, MD; Constance A. Benson, MD; Susan P. Buchbinder, MD; Carlos del Rio, MD; Joseph J. Eron Jr, MD; Huldrych F. Günthard, MD; Jean-Michel Molina, MD; Donna M. Jacobsen, BS; Michael S. Saag, MD
Topics & Concepts
RilpivirineMedicineHuman immunodeficiency virus (HIV)GerontologyFamily medicineAntiretroviral therapyViral loadHIV Research and TreatmentHerpesvirus Infections and TreatmentsHIV/AIDS drug development and treatment